Patent · US Active

Inhibition of replication of oncogenic herpesviruses

US8697095B1 · kind B1 · utility

2Cited by

1References

9Claims

0Family size

Assignee

University of South Florida · US

Inventors

Maria M. Medveczky · Tampa, US
Peter G. Medveczky · Tampa, US
Tracy Sherwood · Riverview, US
Thomas KLEIN · Radolfzell, DE
Herman Friedman · Tampa, US

Key dates

Filing date	Sep 15, 2005
Grant date	Apr 15, 2014
Priority date	—
Expiry date	Jul 13, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/352
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating gamma oncogenic herpesviruses, in vivo, through use of Delta-9 Tetrahydrocannabinol (THC). THC inhibits KSHV and EBV reactivation as well as inhibiting lytic replication of MHV 68 and HVS in vitro. Specifically, THC inhibits immediate early gene ORF 50 promoter activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.